Last month the Committee, the Scientific Advisory Board (SAB) was formally established. On 6 February 2026, the project leadership met online with the board for the first time to kick off the collaboration and discuss priorities for the coming period.
The SAB brings together a strong mix of expertise, including Donna Turner, Tit Albreht, Peter Rijnbeek, Caroline Berchet and Marcis Leja. The board will provide strategic guidance and help ensure that CancerWatch’s technical outputs — from data quality standards to digital registry infrastructure — meet high scientific and policy benchmarks, while also supporting impact and long-term sustainability.
The first meeting focused on the role of Population-Based Cancer Registries (PBCRs) in monitoring trends and evaluating screening programmes across Europe, as well as on key challenges such as data heterogeneity and readiness for the European Health Data Space (EHDS). Going forward, the SAB will act as a strategic compass, helping sharpen the narrative, connect with key stakeholders and strengthen links to Europe’s Beating Cancer Plan.
